Skip to main content
Category

News Archive

Business Trends Icons by Jumsoft on Envato Elements

5 trends VCs, investors and founders are talking about right now | Silicon Valley Bank

By News Archive

Business Trends Icons by Jumsoft on Envato ElementsStartup founders and investors are looking at what could be a murky investment outlook over the next few months or quarters. Slowing markets, rising interest rates and turmoil abroad has caused fluctuation in the markets. While the tech sector may continue providing growth opportunity long term, the near term may also be volatile enough that many founders and investors might be forced to take a different path than originally planned.

 

Read More
Media relations logo 9 92 16

UNH Research Finds Angel Investor Behavior Can Be Influenced by Ego | UNH Today

By News Archive

Media relations logo 9 92 16DURHAM, N.H.—Angel investors—wealthy individuals who provide essential funds for start-ups—often invest under conditions of extreme uncertainty. While their funds can be vital to early-stage ventures, researchers at the University of New Hampshire found that angels’ egos can play a significant role in their investment decisions—the bigger the ego, the larger and more diverse the deal and the lower the number of co-investors.

 

Read More
Investing money into stock market investing comput 2022 08 01 04 22 50 utc

VIPC’s Virginia Venture Partners Invests in Jeeva to Help Increase Patient Diversity in Clinical Trials – EIN Presswire

By News Archive

Investing money into stock market investing comput 2022 08 01 04 22 50 utcRICHMOND, VIRGINIA, UNITED STATES, August 31, 2022 /EINPresswire.com/ — Virginia Venture Partners, the equity investment program of Virginia Innovation Partnership Corporation (VIPC), today announced an investment in Manassas, Va.-based Jeeva. Jeeva provides a scalable eClinical Software as a Service (SaaS) platform that helps sponsors and contract research organizations (CROs) accelerate flexible clinical operations while minimizing burden on site staff and patients. Jeeva will use this investment towards commercialization of the SaaS platform to accelerate therapy development for therapeutic areas such as rare diseases, immunology, and oncology in the U.S. and in emerging markets such as Latin America and India, where the company has recently established strategic partnerships.

 

Read More
FD1500 150x150

The fate of the SBIR program hangs in the balance of the next month | Federal News Network

By News Archive

FD1500 150x150In about 30 days, one of the longest running and most successful small business programs will expire.

The House will have 14 days in September with votes scheduled to reauthorize the Small Business Innovation Research (SBIR) program when it returns to Washington, D.C. after Labor Day. Meanwhile, the Senate reconvenes on Sept. 6 and doesn’t spell out how many days it plans to be in D.C. and voting on bills.

To be sure, the fate of the SBIR program hangs in the balance of what Congress can do by Sept. 30.

 

Read More
Emergent Logo

Sanofi offloads smallpox vaccine business to Emergent BioSolutions in $125M deal | Fierce Pharma

By News Archive

Emergent LogoEmergent BioSolutions is set to add the only FDA-approved smallpox vaccine to its portfolio through a $125 million deal with vaccine giant Sanofi Pasteur.

The agreement means Emergent will inherit an existing CDC contract to build the national stockpile. That 10-year, $425 million contract has around $160 million left to be fulfilled before it ends in 2018. Emergent expects to negotiate a multiyear renewal as part of its involvement in the U.S. government’s counter-bioterrorism effort.

 

Read More
Forum Preview Article for Newsletter jtk delmarvagroup com Delmarva Group LLC Mail

BioBuzz: BioHealth Capital Region Forum 2022 Preview

By News Archive

Forum Preview Article for Newsletter jtk delmarvagroup com Delmarva Group LLC MailThe past few years in the biotech industry have been filled with challenges and promise.

From the rapid and successful deployment of the COVID-19 vaccine and the explosion of the cell and gene therapy sector to a hiring boom, remarkable advances in tissue engineering and strong biomanufacturing growth, the BioHealth Capital Region (BHCR) has played a pivotal role in it all.

To say a lot has changed is the understatement of the century. The question remains, however: Where is the BHCR headed?

Read More
BioTalk Crab Trap Preview gif

7th Annual BioHealth Capital Region Crab Trap Preview

By News Archive

BioTalk Crab Trap Preview gif

Crab Trap Judges and Sponsors, Sally Allain, MSc., MBA Head, JLABS @ Washington, DC Johnson & Johnson Innovation – JLABS, Srujana Cherukuri, Ph.D., Chief Executive Officer, Noble Life Sciences, Inc. & Lora Green, Partner, Wilson Sonsini Goodrich & Rosati, join Rich Bendis on BioTalk to preview the event taking place live on September 21st, 2022 at USP in Rockville. For the first time in its history, this year’s Crab Trap winner will be eligible for a package of prizes worth more than $50,000.

Prizes for the qualifying Crab Trap winner include:

  • A $10,000 cash prize from Wilson Sonsini
  • A $5,000 cash from Montgomery County (for a firm headquartered in Montgomery County)
  • A one-year residency at JLABS @ Washington, D.C.
  • Preclinical CRO services from Noble Life Sciences.

Listen now via Apple https://apple.co/3Kr1FKU, Google https://bit.ly/3e46gGS, Spotify https://spoti.fi/3ctQ4Os, or Amazon Podcasts https://amzn.to/3qbvtSB

Read More

Search

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.